| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
aildenafil
1
relevant articles (0 outcomes,
1 trials/studies)
found for this Bio-Agent
Description: phosphodiesterase V inhibitor; structure in first source
Also Known As:1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4 -ethoxyphenyl)sulfonyl)-cis-3,5-dimethylpiperazine
Bio-Agent Context: Research Results
Experts
| 1. | Yuan, Ren-pei: 1 article (12/2006) |
| 2. | Na, Yan-qun: 1 article (12/2006) |
| 3. | Song, Tao: 1 article (12/2006) |
| 4. | Jiang, Hui: 1 article (12/2006) |
| 5. | Dai, Dong-xi: 1 article (12/2006) |
| 6. | Li, Ning-chen: 1 article (12/2006) |
| 7. | Yang, Yong: 1 article (12/2006) |
| 8. | Zhu, Ji-chuan: 1 article (12/2006) |
| 9. | Bai, Wen-jun: 1 article (12/2006) |
| 10. | He, Zhan-ju: 1 article (12/2006) |
Related Diseases
| 1. | Erectile Dysfunction
12/01/2006
- "METHODS: Integrated analyses were made of 8-week, randomized, double-blind, placebo-controlled phase 2 clinical trials involving 250 men with mild-to-severe erectile dysfunction of various etiologies who received aildenafil citrate 30 or 60 mg (n = 167) or placebo (n = 83)"
12/01/2006 - "Conclusion: The aildenafil citrate therapy significantly ameliorated erectile function and was well tolerated by a wide range of patients with erectile dysfunction." 12/01/2006 - "OBJECTIVE: To evaluate the efficacy and safety of aildenafil citrate, an oral phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction" 12/01/2006 - "Aildenafil citrate: a new potent and highly selective phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction]" Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | Citric Acid (Citrate)
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |